The Prevalence of Toxoplasma gondii in Hemodialysis Patients

Bayani, Masomeh; Mostafazadeh, Amrollah; Farsheed, Oliaee; Kalantari, Narges

doi:10.5812/ircmj.5225

Cited by 20 publications

(25 citation statements)

References 5 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This picture of high prevalence of seropositivity in general population is also shown in two other reports from the north part of Iran [6,9]. This is the first report of seroprevalence of Toxoplasma in PD patients.…”

Section: Discussionsupporting

confidence: 84%

“…There are some reports about the existence of T. gondii in hemodialysis (HD) patients. Some studies suggested that exposure to hemodialysis is related to the seropositivity of Toxoplasma, but there is no evidence about the seroprevalence of Toxoplasma in peritoneal dialysis (PD) population [6][7][8]. The aim of present investigation was to clarify T. gondii seropositivity in a group of PD patients and to compare it with HD patients results and the seropositivity of general population in a highly prevalent local in Northwest Iran.…”

Section: Introductionmentioning

confidence: 92%

See 1 more Smart Citation

Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients

Hamidi¹,

Etemadi²,

Mehrabani³

et al. 2015

J Coast Life Med

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 84%

Section: Introductionmentioning

confidence: 92%

Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients

Hamidi¹,

Etemadi²,

Mehrabani³

et al. 2015

J Coast Life Med

View full text Add to dashboard Cite

“…In recent studies, T. gondii IgG seropositivity was detected in 60% of HD patients and 40% of the healthy control group (P > 0.05) in Babol (North Iran). 23 Ebrahim Zadeh et al 24 detected T. gondii IgG antibody among 56.7% of HD patients and 29.7% of the control group (p ¼ 0.036) in Zahedan (South-East Iran). T. gondii IgM antibody was also detected in 13.5% of the case and none of the control group.…”

Section: Discussionmentioning

confidence: 97%

“…[13][14][15][16][17][18][19][20] Moreover, higher seroprevalence of toxoplasmosis has been reported in hemodialysis and chronic renal failure patients. 12,23,25,32 The diagnosis of toxoplasmosis is based on serology. If an individual was IgM or IgM þ IgG positive, the patient has an active infection.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran

et al. 2016

View full text Add to dashboard Cite

Toxoplasma gondii is one of the important opportunistic pathogen among solid-organ transplant recipients and hemodialysis patients (HD). This study was aimed to detect toxoplasmosis among 50 renal transplant recipients (RTR), 135 HD and 120 healthy individuals in two cities (Kashan and Qom) that located in the center of Iran, from 2014 to 2015. Serological detection (IgG and IgM antibodies) was performed among all individuals in case and control groups. Molecular detection was performed on all IgM positive individuals or IgG positive with moderate to high (>51 IU/mL) antibody titers in HD (n ¼ 42) and control groups (n ¼ 21). In RTR patients, molecular detection was conducted among all seropositive or seronegative individuals (n ¼ 50). IgG seropositivity was detected in 52% (26/50) of RTR, 63% (85/135) of HD and 33.3% (40/120) of the control group. The rate of anti-T. gondii IgG antibody was significantly elevated in RTR and HD patients than the control group (p ¼ 0.023 and p < 0.001, respectively). IgM seropositivity was only detected in one HD patient. T. gondii DNA was detected in 12% (6/50) of RTR and 7.1% (3/42) of HD patients. The results of this study suggested that the screening of toxoplasmosis should be given greater consideration among RTR and hemodialysis patients. ARTICLE HISTORY

show abstract

Is COVID-19 associated with latent toxoplasmosis?

Ghaffari

Kalantari

Gorgani-Firouzjaee

et al. 2021

Environ Sci Pollut Res

Self Cite

View full text Add to dashboard Cite

The present study aimed to evaluate the possible association between coronavirus disease 2019 (COVID-19) and latent Toxoplasma gondii infection in a group of patients and healthy individuals. Blood samples were obtained from 269 PCR-positive COVID-19 patients. The serum was separated and tested for the existence of anti- T. gondii antibodies (IgG) using a commercial enzyme-linked immunosorbent assay kit. The prevalence of latent toxoplasmosis between a subgroup of the patients (aged under 55 years old) and COVID-19 negative individuals was compared. Anti- T. gondii antibodies were found in 226/269 (84.0%) patients with COVID-19. Anti- Toxoplasma antibodies were detected in 72/91 (79.1%) cases and 96/123 (78.0%) COVID-19 negative individuals (odd ratio = 1.1; 95% confidence interval: 0.55–2.07, P = 0.85). The median and interquartile range (IQR) of the IgG titer were not statistically significant different between case (97.3 [31.0–133.5]) and control groups (34.4 [13.0–144.5]) ( P = 0.10). These findings demonstrated that latent Toxoplasma infection is prevalent amongst the COVID-19 patients. It also did not find any significant association between chronic toxoplasmosis and COVID-19.

show abstract

The Prevalence of Toxoplasma gondii in Hemodialysis Patients

Cited by 20 publications

References 5 publications

Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients

Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients

Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran

Is COVID-19 associated with latent toxoplasmosis?

Contact Info

Product

Resources

About